Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2021-03-30 2021-03-29
Drug Identification Number 02248453 02248453
Brand name GLICLAZIDE-80 GLICLAZIDE-80
Common or Proper name GLICLAZIDE 80 GLICLAZIDE 80
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients GLICLAZIDE GLICLAZIDE
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60,100 60,100
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-03-29 2021-03-29
Remaining supply date 2022-01-31 2022-01-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments